Target intelligence / Profile preview

Ischemic neuronal cells

Molecular classification
Other
01

Overview

Ischemic neuronal cells are neurons that have been compromised by a lack of sufficient blood flow, leading to oxygen and glucose deprivation. This ischemic insult initiates a rapid failure of adenosine triphosphate (ATP) production, causing the breakdown of ion pumps and subsequent membrane depolarization. This state leads to the massive release of excitatory neurotransmitters like glutamate, triggering calcium overload and downstream cascades of oxidative stress, mitochondrial dysfunction, and eventually cell death via necrosis or apoptosis [6], [7]. While "ischemic neuronal cells" describes a physiological state rather than a single molecular target, they are the primary focus of neuroprotective and thrombolytic therapies aimed at salvaging brain tissue in the penumbra during acute stroke [4], [10]. Pharmacological interventions typically target specific molecular pathways within these cells, such as NMDA receptors, sodium channels, or radical scavenging systems, to mitigate the progression of damage [3], [5].

Other names
Ischemic neuronsHypoxic neuronsPenumbra neuronsOxygen-glucose deprived neurons
02

Mechanism of action

Restoration of blood flow via thrombolysis, reduction of glutamate-mediated excitotoxicity through receptor antagonism, and mitigation of oxidative damage via free radical scavenging [3], [4], [10].

03

Biological functions

ApoptosisCell deathExcitotoxicitySignal transductionOther
04

Disease associations

Neurodegenerative diseaseOther
05

Safety considerations

Hemorrhagic transformation [10]Reperfusion injury [10]Narrow therapeutic window [4]Blood-brain barrier disruption [6]
06

Interacting drugs

Alteplase

4 more in the full profile.

07

Biomarkers

Neuron-specific enolase (NSE)S100 calcium-binding protein B (S100B)CircOGDH [1]Glial fibrillary acidic protein (GFAP)

Beyond the preview

Go deeper on Ischemic neuronal cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ischemic neuronal cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call